Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia

被引：1
|
作者：
Schimmer, Aaron D. [1 ]
Skrtic, Marko [1 ]
机构：
[1] Princess Margaret Hosp, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada
来源：
EXPERT REVIEW OF HEMATOLOGY | 2012年 / 5卷 / 02期
基金：
加拿大健康研究院;
关键词：
leukemia; mitochondrial translation; stem cells; TIGECYCLINE; INITIATION; SINGLE; CELLS;
D O I：
10.1586/EHM.12.8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 119
页数：3
相关论文
共 50 条
  • [31] INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA
    Antony-Debre, Ileana
    Leite, Joana
    Paul, Ananya
    Mitchell, Kelly
    Kim, Hye Mi
    Huang, Kenneth
    Kumar, Arvind
    Farahat, Abdelbasset A.
    Bartholdy, Boris
    Narayanagari, Swathi-Rao
    Carvajal, Luis A.
    Chen, Jiahao
    Ambesi-Impiombato, Alberto
    Ferrando, Adolfo A.
    Mantzaris, Ioannis
    Gavathiotis, Evripidis
    Verma, Amit
    Will, Britta
    Boykin, David W.
    Wilson, W. David
    Poon, Gregory M. K.
    Steidl, Ulrich
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S133 - S133
  • [32] INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA
    Antony-Debre, I.
    Leite, J.
    Paul, A.
    Mitchell, K.
    Kim, H. M.
    Huang, K.
    Kumar, A.
    Farahat, A. A.
    Bartholdy, B.
    Narayanagari, S. -R.
    Carvajal, L. A.
    Chen, J.
    Ambesi-Impiombato, A.
    Ferrando, A. A.
    Mantzaris, I.
    Gavathiotis, E.
    Verma, A.
    Will, B.
    Boykin, D. W.
    Wilson, W. D.
    Poon, G. M. K.
    Steidl, U.
    HAEMATOLOGICA, 2017, 102 : 18 - 18
  • [33] Axl inhibition: a potential road to a novel acute myeloid leukemia therapy?
    Janning, Melanie
    Ben-Batalla, Isabel
    Loges, Sonja
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 135 - 138
  • [34] Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition
    Greiner, Jochen
    Hofmann, Susanne
    Schmitt, Michael
    Goetz, Marlies
    Wiesneth, Markus
    Schrezenmeier, Hubert
    Bunjes, Donald
    Doehner, Hartmut
    Bullinger, Lars
    HAEMATOLOGICA, 2017, 102 (12) : 499 - 501
  • [35] Therapeutic Advances in Acute Myeloid Leukemia
    Burnett, Alan
    Wetzler, Meir
    Loewenberg, Bob
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : 487 - 494
  • [36] Acute myeloid leukemia: therapeutic indications
    Burnett, AK
    Kell, J
    Rowntree, C
    CURRENT OPINION IN HEMATOLOGY, 2000, 7 (06) : 333 - 338
  • [37] Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
    Chen, Xufeng
    Glytsou, Christina
    Zhou, Hua
    Narang, Sonali
    Reyna, Denis E.
    Lopez, Andrea
    Sakellaropoulos, Theodore
    Gong, Yixiao
    Kloetgen, Andreas
    Yap, Yoon Sing
    Wang, Eric
    Gavathiotis, Evripidis
    Tsirigos, Aristotelis
    Tibes, Raoul
    Aifantis, Iannis
    CANCER DISCOVERY, 2019, 9 (07) : 890 - 909
  • [38] GLYCOLYSIS INHIBITION ON ACUTE MYELOID LEUKEMIA
    Mirabilii, S.
    Ricciardi, M. R.
    Allegretti, M.
    Licchetta, R.
    Foa, R.
    Tafuri, A.
    HAEMATOLOGICA, 2014, 99 : 295 - 296
  • [39] Suppression of c-Myc by PAM pathway inhibition and ATRA treatment for therapeutic gain in acute myeloid leukemia
    Schenk, T.
    Stengel, S.
    Kahl, M.
    Rodriguez, A.
    Perez, A.
    Swords, R. T.
    Petrie, K.
    Zelent, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 145 - 145
  • [40] Treatment of Acute Myeloid Leukemia in Elderly Patients-A Therapeutic Dilemma
    Mamdani, Hirva
    Dos Santos, Cedric
    Konig, Heiko
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (07) : 581 - 587
12345